EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness

Ting-Feng Hsiao iD, Chih-Liang Wang, Yi-Cheng Wu, Chia-Yu Kuo, Ke-Wei Lin, Wen-Yu Chuang, Chi-Ju Yeh, Chia-Chun Wu, Ko-Jiunn Liu, Gee-Chen Chang, Kun-Yi Chien iD, Jau-Song Yu und 1 weitere

Journal of Proteome Research · 2025

DOI: 10.1021/acs.jproteome.5c00385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Ting-Feng Hsiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chang Gung University, Chang Gung Memorial Hospital, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have transformed lung adenocarcinoma (LUAD) treatment in EGFR-mutant (MT) patients, but strategies targeting wild-type (WT) EGFR tumors remain necessary. This study analyzed a diverse LUAD patient cohort with EGFR mutation statuses and wild-type profiles for ALK and KRAS to identify stage-specific biomarkers. Using quantitative proteomics and multiomics, we discovered 21 dysregulated proteins in early-stage EGFR-WT LUAD, identifying myeloid-derived growth factor (MYDGF) as a key candidate biomarker. Elevated MYDGF levels in tissue (n = 117) and serum (n = 196) correlated significantly with cancer stage in EGFR-WT patients but not EGFR-MT cases. Notably, a higher tumor-to-normal MYDGF ratio predicted a favorable prognosis in early-stage EGFR-WT LUAD. Functional studies demonstrated that MYDGF exerts distinct roles in cell viability and migration depending on its cellular localization and the invasive potential of cancer cells. Specifically, secreted MYDGF promoted a protumorigenic phenotype, whereas excess intracellular MYDGF appeared to suppress the oncogenic capacity of aggressive cancer cells. MYDGF knockdown and subsequent proteomic analysis provided further insights into these context-dependent functions. These findings highlight EGFR status- and stage-specific proteomic profiles in LUAD, emphasizing the importance of context-dependent biomarker assessment for personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsCarcinogenesisHumansErbB ReceptorsBiomarkers, TumorFemaleProteomicsMaleMutationCell Line, TumorMiddle AgedCell MovementPrognosisGene Expression Regulation, NeoplasticAged

Stichwörter der Autor:innen

biomarkerlung adenocarcinomamyeloid-derived growth factorquantitative proteomicswild-type EGFR

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan.
  • School of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.
  • Department of Thoracic Surgery, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.
  • Department of Pathology, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.

ORCID-Profile: Ting-Feng Hsiao, Kun-Yi Chien, Chia-Jung Yu

Förderung

  • Chang Gung University
  • Chang Gung Memorial Hospital
  • National Science and Technology Council
  • Ministry of Education, Taiwan

Zitieren

APA

Hsiao, T. F., Wang, C. L., Wu, Y. C., Kuo, C. Y., Lin, K. W., Chuang, W. Y., Yeh, C. J., Wu, C. C., Liu, K. J., Chang, G. C., Chien, K. Y., Yu, J. S., & Yu, C. J. (2025). Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00385

Vancouver

Hsiao TF, Wang CL, Wu YC, Kuo CY, Lin KW, Chuang WY, et al. Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00385

BibTeX
@article{Hsiao2025,
  author = {Hsiao, Ting-Feng and Wang, Chih-Liang and Wu, Yi-Cheng and Kuo, Chia-Yu and Lin, Ke-Wei and Chuang, Wen-Yu and Yeh, Chi-Ju and Wu, Chia-Chun and Liu, Ko-Jiunn and Chang, Gee-Chen and Chien, Kun-Yi and Yu, Jau-Song and Yu, Chia-Jung},
  title = {Myeloid-Derived Growth Factor-Regulated Oncogenesis in Lung Adenocarcinoma Is Associated with EGFR Status and Cancer Aggressiveness},
  journal = {Journal of Proteome Research},
  year = {2025},
  doi = {10.1021/acs.jproteome.5c00385}
}
Kostenlos starten →